UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

The lancet oncology, 2022-09, Vol.23 (9), p.1180-1188

2022

Link zum Volltext

Verfügbarkeit prüfen

Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study)

BMC cancer, 2021-06, Vol.21 (1), p.1-711, Article 711

2021

Link zum Volltext

Verfügbarkeit prüfen

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

Targeted oncology, 2022-11, Vol.17 (6), p.675-682

2022

Link zum Volltext

Verfügbarkeit prüfen

Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

Cancer letters, 2019-03, Vol.444, p.147-161

2019

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of extracranial stereotactic body radiation therapy

BMC cancer, 2021-02, Vol.21 (1)

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4304: Radio-chemotherapy efficacy is predicted by intra-tumor CD8+FoxP3+ double positive T cell density in locally advanced non-small cell lung carcinoma

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.4304-4304

2020

Link zum Volltext

Verfügbarkeit prüfen

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians

Oncotarget, 2017-08, Vol.8 (31), p.50792-50803

2017

Link zum Volltext

Verfügbarkeit prüfen

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e20633-e20633

2016

Link zum Volltext

Verfügbarkeit prüfen

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Biotechnology research international, 2016, Vol.2016, p.1-7

2016

Link zum Volltext

Verfügbarkeit prüfen

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Clinical medicine insights. Therapeutics, 2010-01, Vol.2, p.179

2010

Link zum Volltext

Verfügbarkeit prüfen

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e20543-e20543

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.2231-2231

2014

Link zum Volltext

Verfügbarkeit prüfen

Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts

ESMO open, 2024-06, Vol.9 (6), p.103594, Article 103594

2024

Link zum Volltext

Verfügbarkeit prüfen

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Link zum Volltext

Verfügbarkeit prüfen

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1182-S1183

2017

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.7511-7511

2014

Link zum Volltext

Verfügbarkeit prüfen

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.TPS7111-TPS7111

2012

Link zum Volltext

Verfügbarkeit prüfen

Adenocarcinoma of the lung in Down syndrome: first clinical report

Tumori, 2013-07, Vol.99 (4), p.e169-e171

2013

Link zum Volltext

Verfügbarkeit prüfen

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

The Lancet regional health. Europe, 2022-11, Vol.22, p.100492-100492, Article 100492

2022

Link zum Volltext

Verfügbarkeit prüfen

Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature

Journal de médecine vasculaire, 2021-04, Vol.46 (2), p.53-65

2021

Link zum Volltext

Verfügbarkeit prüfen

Épidémiologie du cancer bronchique : Cancer bronchique

Médecine thérapeutique : MT, 2001, Vol.7 (7), p.499-505

2001

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

Zeitschrift / SerieBulletin Du Cancer

ThemaBiological And Medical Sciences

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial

Risk of lung cancer among women in relation to lifetime history of tobacco smoking: a population-based case-control study in France (the WELCA study)

Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study

Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody

Does Very Poor Performance Status Systematically Preclude Single Agent Anti-PD-1 Immunotherapy? A Multicenter Study of 35 Consecutive Patients

Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial

Efficacy of extracranial stereotactic body radiation therapy

Abstract 4304: Radio-chemotherapy efficacy is predicted by intra-tumor CD8+FoxP3+ double positive T cell density in locally advanced non-small cell lung carcinoma

Impact of country of birth on genetic testing of metastatic lung adenocarcinomas in France: African women exhibit a mutational spectrum more similar to Asians than to Caucasians

Real-life efficacy and safety of nivolumab for non-small cell lung cancer: A 10-months French cohort

Challenges in Diagnosis and Treatment of Lung Cancer in People with Intellectual Disabilities: Current State of Knowledge

Pharmacotherapy Update: Vinorelbine in the Treatment of Non-small-cell Lung Cancer

Real-life use of nivolumab in non-small cell lung cancer: A multicentric cohort to determine its clinical efficacy and predictive factors of early progression

Abstract 2231: The prevalence of EGFR and KRAS mutations in a population of African immigrants in France is closer to that of Asian populations than to white Europeans

Risk factors for early mortality from lung cancer: evolution over the last 20 years in the French nationwide KBP cohorts

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial: Topic: Miscellaneous

P3.02a-034 Vemurafenib in Patients with Non-Small Cell Lung Cancer (NSCLC) Harboring BRAF Mutation. Preliminary Results of the AcSé Trial

Phase II study of cetuximab, pemetrexed, cisplatin and concurrent radiotherapy in patients with locally advanced, unresectable, stage III, non-squamous, non-small cell lung cancer (NSCLC): Results of the IFCT-0803 trial

Postoperative follow-up of lung cancer: Randomized trial comparing two follow-up programs in completely resected non-small cell lung cancer (IFCT-0302)

Adenocarcinoma of the lung in Down syndrome: first clinical report

Lung cancer trends and tumor characteristic changes over 20 years (2000–2020): Results of three French consecutive nationwide prospective cohorts’ studies

Patients with atherosclerotic peripheral arterial disease have a high risk of lung cancer: Systematic review and meta-analysis of literature

Épidémiologie du cancer bronchique : Cancer bronchique

Aktive Filter

Suchergebnisse filtern